Characteristics and clinical significance of histological variants of bladder cancer

[1]  Yair Lotan,et al.  Treatment of Non‐Metastatic Muscle‐Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline , 2017, The Journal of urology.

[2]  F. Montorsi,et al.  Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients , 2017, Clinical genitourinary cancer.

[3]  A. Sidana,et al.  Genitourinary paraganglioma: Demographic, pathologic, and clinical characteristics in the surveillance, epidemiology, and end results database (2000-2012). , 2017, Urologic oncology.

[4]  A. Roychoudhury,et al.  Contemporary treatment patterns and outcomes of sarcomatoid bladder cancer , 2017, World Journal of Urology.

[5]  F. Montorsi,et al.  Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy. , 2017, Urologic oncology.

[6]  T. Klatte,et al.  Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy , 2017, Clinical genitourinary cancer.

[7]  Maximilian Burger,et al.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. , 2017, European urology.

[8]  E. Compérat,et al.  Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. , 2017, European urology.

[9]  K. Bensalah,et al.  HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC) , 2017, World Journal of Urology.

[10]  A. Roychoudhury,et al.  Micropapillary Bladder Cancer: Insights from the National Cancer Database , 2016, Bladder cancer.

[11]  J. Weinstein,et al.  Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer. , 2016, European urology.

[12]  M. Babjuk,et al.  The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Proto , 2016, European urology.

[13]  Holger Moch,et al.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours. , 2016, European urology.

[14]  P. Humphrey,et al.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. , 2016, European urology.

[15]  G. Hidas,et al.  The Response of Variant Histology Bladder Cancer to Intravesical Immunotherapy Compared to Conventional Cancer , 2016, Front. Oncol..

[16]  Jeong Hwan Park,et al.  HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder , 2016, Disease markers.

[17]  B. Taylor,et al.  Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer , 2016, Nature Genetics.

[18]  K. Guru,et al.  Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma. , 2016, Clinical Genitourinary Cancer.

[19]  W. Mackillop,et al.  Outcomes of squamous histology in bladder cancer: a population-based study. , 2015, Urologic oncology.

[20]  Liang Cheng,et al.  The changing reality of urothelial bladder cancer: should non‐squamous variant histology be managed as a distinct clinical entity? , 2015, BJU international.

[21]  A. Masson-Lecomte,et al.  Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy , 2015, World Journal of Urology.

[22]  K. Ogan,et al.  Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases. , 2015, The Canadian journal of urology.

[23]  Qun He,et al.  Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy , 2015, BMC Urology.

[24]  B. Czerniak,et al.  Clinical outcomes of cT1 micropapillary bladder cancer. , 2015, The Journal of urology.

[25]  F. Montorsi,et al.  Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens. , 2014, Urology.

[26]  M. Rouprêt,et al.  Impact of histological variants on the outcomes of nonmuscle invasive bladder cancer after transurethral resection , 2014, Current opinion in urology.

[27]  K. Mai,et al.  Nested and microcystic variants of urothelial carcinoma displaying immunohistochemical features of basal‐like urothelial cells: An immunohistochemical and histopathogenetic study , 2014, Pathology international.

[28]  E. Messing,et al.  Micropapillary bladder cancer: current treatment patterns and review of the literature. , 2014, Urologic oncology.

[29]  Liang Cheng,et al.  Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm? , 2014, Urologic oncology.

[30]  M. Krzywinski,et al.  Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib , 2014, Cancer biology & therapy.

[31]  A. Venyo.  Primary Clear Cell Carcinoma of the Urinary Bladder , 2014, International scholarly research notices.

[32]  R. Montironi,et al.  Clinicopathological characteristics and outcome of nested carcinoma of the urinary bladder , 2014, Virchows Archiv.

[33]  Liang Cheng,et al.  Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planes. , 2014, Urology.

[34]  R. Montironi,et al.  Microcystic urothelial carcinoma: morphology, immunohistochemistry and clinical behaviour , 2014, Histopathology.

[35]  J. Cheville,et al.  Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome , 2014, Modern Pathology.

[36]  M. Tachibana,et al.  Sarcomatoid Carcinoma of the Urinary Bladder , 2014 .

[37]  S. Daneshmand,et al.  Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy. , 2014, Urologic oncology.

[38]  Kai Wang,et al.  A High Frequency of Activating Extracellular Domain ERBB2 (HER2) Mutation in Micropapillary Urothelial Carcinoma , 2013, Clinical Cancer Research.

[39]  R. Shah,et al.  Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital. , 2013, Urologic oncology.

[40]  Dieter Jocham,et al.  Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. , 2013, European urology.

[41]  A. Bansal,et al.  Sarcomatoid variant of urothelial carcinoma of the urinary bladder. , 2013, Journal of cancer research and therapeutics.

[42]  M. Babjuk,et al.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. , 2013, European urology.

[43]  S. Porten,et al.  Should histologic variants alter definitive treatment of bladder cancer? , 2013, Current opinion in urology.

[44]  R. Millikan,et al.  Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center. , 2013, European urology.

[45]  B. Bochner,et al.  Pathological response to neoadjuvant chemotherapy for muscle‐invasive micropapillary bladder cancer , 2013, BJU international.

[46]  P. Rambau,et al.  Schistosomiasis and urinary bladder cancer in North Western Tanzania: a retrospective review of 185 patients , 2013, Infectious Agents and Cancer.

[47]  B. Shuch,et al.  Low Grade Micropapillary Urothelial Carcinoma, Does It Exist? - Analysis of Management and Outcomes from the Surveillance, Epidemiology and End Results (SEER) Database , 2013, Journal of Cancer.

[48]  J. Cheville,et al.  Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis. , 2013, The Journal of urology.

[49]  David A. Green,et al.  Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. , 2013, European journal of cancer.

[50]  R. Millikan,et al.  Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis. , 2013, The Journal of urology.

[51]  V. Reuter,et al.  Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder. , 2013, The Journal of urology.

[52]  D. Hansel,et al.  The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy. , 2013, The Journal of urology.

[53]  M. Rotman,et al.  Characterization and Outcomes of Small Cell Carcinoma of the Bladder Using the Surveillance, Epidemiology, and End Results Database , 2013, American journal of clinical oncology.

[54]  T. Hasegawa,et al.  A case of urothelial carcinoma, lipid cell variant , 2013, Pathology international.

[55]  M. Stöckle,et al.  Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy , 2013, BMC Cancer.

[56]  J. Cheville,et al.  The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma. , 2012, The Journal of urology.

[57]  D. Casalino,et al.  Imaging features of common and uncommon bladder neoplasms. , 2012, Radiologic clinics of North America.

[58]  A. Sangoi,et al.  Plasmacytoid carcinoma of the bladder: a urothelial carcinoma variant with a predilection for intraperitoneal spread. , 2012, The Journal of urology.

[59]  F. Montorsi,et al.  Survival after radical cystectomy of non‐bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing‐risks analysis , 2012, BJU international.

[60]  H. Salem,et al.  Changing patterns (age, incidence, and pathologic types) of schistosoma-associated bladder cancer in Egypt in the past decade. , 2012, Urology.

[61]  E. Koay,et al.  A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder , 2011, Cancer.

[62]  Nabil Ismaili,et al.  A rare bladder cancer - small cell carcinoma: review and update , 2011, Orphanet journal of rare diseases.

[63]  J. Epstein,et al.  Large Nested Variant of Urothelial Carcinoma: 23 Cases Mimicking von Brunn Nests and Inverted Growth Pattern of Noninvasive Papillary Urothelial Carcinoma , 2011, The American journal of surgical pathology.

[64]  E. Messing,et al.  DO MIXED HISTOLOGICAL FEATURES AFFECT SURVIVAL BENEFIT FROM NEOADJUVANT PLATINUM‐BASED COMBINATION CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED BLADDER CANCER? , 2011, BJU international.

[65]  A. Franchi,et al.  Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series. , 2011, Human pathology.

[66]  M. Parmar,et al.  International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  R. Montironi,et al.  Sarcomatoid Carcinoma of the Urinary Bladder: The Final Common Pathway of Urothelial Carcinoma Dedifferentiation , 2011, The American journal of surgical pathology.

[68]  R. Montironi,et al.  Glandular lesions of the urinary bladder:clinical significance and differential diagnosis , 2011, Histopathology.

[69]  C. Ching,et al.  HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization , 2011, Modern Pathology.

[70]  M. Duvdevani,et al.  Is radical cystectomy mandatory in every patient with variant histology of bladder cancer , 2011, Rare tumors.

[71]  W. Lowrance,et al.  Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy. , 2011, The Journal of urology.

[72]  S. Campbell,et al.  Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder. , 2011, Urology.

[73]  R. Shah,et al.  Lymphoepithelioma-like Carcinoma of the Urinary Bladder: Clinicopathologic, Immunohistochemical, and Molecular Features , 2011, The American journal of surgical pathology.

[74]  R. Knuechel,et al.  Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer , 2011, Virchows Archiv.

[75]  D. Grignon,et al.  E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinoma , 2011, Modern Pathology.

[76]  H. Samaratunga,et al.  Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases , 2010, Pathology.

[77]  E. Messing,et al.  Do mixed histological features affect survival benefit from neoadjuvant platinum‐based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group‐Directed Intergroup Study (S8710) , 2010, BJU international.

[78]  Yoon Hyung Lee,et al.  Lymphoepithelioma-like Carcinoma of the Urinary Bladder , 2010, Journal of Korean medical science.

[79]  K. Stamatiou,et al.  Sarcomatoid Carcinoma of the Urinary Bladder: A Clinicopathological Study of 4 Cases and a Review of the Literature , 2010, Korean journal of urology.

[80]  Andrew H. Beck,et al.  Interobserver Reproducibility in the Diagnosis of Invasive Micropapillary Carcinoma of the Urinary Tract Among Urologic Pathologists , 2010, The American journal of surgical pathology.

[81]  Chad A. LaGrange,et al.  Clinical Features of Sarcomatoid Carcinoma (Carcinosarcoma) of the Urinary Bladder: Analysis of 221 Cases , 2010, Sarcoma.

[82]  M. Paglierani,et al.  Clear cell carcinoma of the bladder in a patient with a earlier clear cell renal cell carcinoma: a case report with morphologic, immunohistochemical, and cytogenetical analysis. , 2010, Applied immunohistochemistry & molecular morphology : AIMM.

[83]  D. Hansel,et al.  Emerging Concepts in Micropapillary Urothelial Carcinoma , 2010, Advances in anatomic pathology.

[84]  J. McKenney,et al.  Urothelial Carcinoma of the Bladder, Lipid Cell Variant: Clinicopathologic Findings and LOH Analysis , 2010, The American journal of surgical pathology.

[85]  L. Kiemeney,et al.  Clinical epidemiology of nonurothelial bladder cancer: analysis of the Netherlands Cancer Registry. , 2010, The Journal of urology.

[86]  F. Montorsi,et al.  Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality. , 2010, Urology.

[87]  R. Shah,et al.  Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases. , 2010, Human pathology.

[88]  P. Tamboli,et al.  Clear cell adenocarcinoma of the urinary bladder: a short review. , 2009, Archives of pathology & laboratory medicine.

[89]  R. Montironi,et al.  Pleomorphic giant cell carcinoma of the urinary bladder. , 2009, Human pathology.

[90]  P. Tamboli,et al.  Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases. , 2009, Human pathology.

[91]  L. A. Jones,et al.  Carcinosarcoma of the urinary bladder following cyclophosphamide therapy: evidence for monoclonal origin and chromosome 9p allelic loss. , 2009, Archives of pathology & laboratory medicine.

[92]  J. Epstein,et al.  Noninvasive Urothelial Carcinoma of the Bladder With Glandular Differentiation: Report of 24 Cases , 2009, The American journal of surgical pathology.

[93]  J. Machiels,et al.  A single‐arm, multicenter, open‐label phase 2 study of lapatinib as the second‐line treatment of patients with locally advanced or metastatic transitional cell carcinoma , 2009, Cancer.

[94]  R. Shah,et al.  Multiple adverse histological features increase the odds of under staging T1 bladder cancer. , 2009, The Journal of urology.

[95]  R. Montironi,et al.  Plasmacytoid urothelial carcinoma of the bladder. , 2009, Human pathology.

[96]  P. Thall,et al.  Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[97]  Mahul B Amin,et al.  Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications , 2009, Modern Pathology.

[98]  E. Messing,et al.  Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment? , 2009, Urology.

[99]  N. Cook,et al.  Small cell carcinoma of the urinary bladder: a 15‐year retrospective review of treatment and survival in the Anglian Cancer Network , 2009, BJU international.

[100]  S. Horenblas,et al.  Long-term survival after sequential chemoradiation for limited disease small cell carcinoma of the bladder , 2009, World Journal of Urology.

[101]  M. Banerjee,et al.  The changing patterns of bladder cancer in Egypt over the past 26 years , 2008, Cancer Causes & Control.

[102]  C. Dinney,et al.  Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder. , 2007, The Journal of urology.

[103]  S. Campbell,et al.  Squamous Cell Carcinoma of the Bladder: A Clinicopathologic Analysis of 45 Cases , 2007, The American journal of surgical pathology.

[104]  B. Czerniak,et al.  Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder , 2007, Cancer.

[105]  T. Braun,et al.  Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection. , 2007, Urology.

[106]  P. Russo,et al.  Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract. , 2007, Urology.

[107]  Liang Cheng,et al.  Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications. , 2006, Human pathology.

[108]  K. Tobisu,et al.  Urothelial carcinoma (clear cell variant) diagnosed with useful immunohistochemistry stain , 2006, International journal of urology : official journal of the Japanese Urological Association.

[109]  R. Millikan,et al.  The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma. , 2006, The Journal of urology.

[110]  S. Groshen,et al.  Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience. , 2005, The Journal of urology.

[111]  H. Grossman,et al.  Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients , 2005 .

[112]  N. Choong,et al.  Small cell carcinoma of the urinary bladder , 2005, Cancer.

[113]  F. Guillé,et al.  Non‐transitional cell bladder carcinomas , 2005, BJU international.

[114]  C. Moran,et al.  Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases , 2005, Histopathology.

[115]  Ximing J. Yang,et al.  Small cell carcinoma of the urinary bladder , 2004, Cancer.

[116]  R. Millikan,et al.  Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. , 2004, The Journal of urology.

[117]  Nicholas J Vogelzang,et al.  Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. , 2003, The New England journal of medicine.

[118]  M. Lisanti,et al.  Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation. , 2003, American journal of clinical pathology.

[119]  A. Lopez‐Beltran,et al.  Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer , 2002, Journal of clinical pathology.

[120]  R. Hautmann,et al.  Immunohistomorphologic and molecular cytogenetic analysis of a carcinosarcoma of the urinary bladder , 2002, Virchows Archiv.

[121]  J. Epstein,et al.  In Situ Adenocarcinoma of the Bladder , 2001, The American journal of surgical pathology.

[122]  R. Montironi,et al.  Lymphoepithelioma-like carcinoma of the urinary bladder: a clinicopathologic study of 13 cases , 2001, Virchows Archiv.

[123]  Y. Imamura,et al.  Small Cell Carcinoma of the Bladder , 2000, Acta Cytologica.

[124]  J. Maranchie,et al.  Clinical and pathological characteristics of micropapillary transitional cell carcinoma: a highly aggressive variant. , 2000, The Journal of urology.

[125]  M. El-baz,et al.  Primary adenocarcinoma of the urinary bladder: a report of 185 cases. , 1998, British journal of urology.

[126]  Young Rh,et al.  Myxoid and sclerosing sarcomatoid transitional cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 25 cases. , 1997 .

[127]  E. Oliva,et al.  Transitional cell carcinomas of the urinary bladder that may be underdiagnosed. A report of four invasive cases exemplifying the homology between neoplastic and non-neoplastic transitional cell lesions. , 1996, The American journal of surgical pathology.

[128]  M. Soloway,et al.  Small cell carcinoma of the bladder and prostate. , 1995, Urology.

[129]  Mahul B. Amin,et al.  Micropapillary Variant of Transitional Cell Carcinoma of the Urinary Bladder Histologic Pattern Resembling Ovarian Papillary Serous Carcinoma , 1994, The American journal of surgical pathology.

[130]  D. Grignon,et al.  Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases , 1992, Cancer.

[131]  R. Young,et al.  Microcystic transitional cell carcinomas of the urinary bladder. A report of four cases. , 1991, American journal of clinical pathology.

[132]  D. Grignon,et al.  Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases , 1991, Cancer.

[133]  I. Magrath,et al.  A randomized pilot study of high-dose epirubicin as neoadjuvant chemotherapy in the treatment of cancer of the bilharzial bladder. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[134]  R. Young,et al.  Carcinomas of the Urinary Bladder with Deceptively Benign‐Appearing Foci: A Report of Three Cases , 1989, The American journal of surgical pathology.

[135]  P. Carroll,et al.  Primary signet-ring cell carcinoma of urinary bladder. , 1989, Urology.

[136]  P. Hartge,et al.  Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder. , 1988, Cancer research.

[137]  S. Mills,et al.  Small Cell Undifferentiated Carcinoma of the Urinary Bladder: A Light-Microscopic, Immunocytochemical, and Ultrastructural Study of 12 Cases , 1987, The American journal of surgical pathology.

[138]  R. Scully,et al.  Clear cell adenocarcinoma of the bladder and urethra: A report of three cases and review of the literature , 1985, The American journal of surgical pathology.

[139]  Chia‐Sui Kao,et al.  Lymph node metastases in patients with urothelial carcinoma variants: influence of the specific variant on nodal histology. , 2015, Urologic oncology.

[140]  Liang Cheng,et al.  Contemporary bladder cancer: variant histology may be a significant driver of disease. , 2015, Urologic oncology.

[141]  R. Millikan,et al.  Refining patient selection for neoadjuvant chemotherapy before radical cystectomy. , 2014, The Journal of urology.

[142]  S. Hazell,et al.  Lymphoepithelioma-like carcinoma of the urinary bladder: A case report and review of systemic treatment options , 2012, Urology annals.

[143]  T. Terada.  Small cell carcinoma of the urinary bladder. , 2012, International journal of clinical and experimental pathology.

[144]  O. Fadare,et al.  Pleomorphic lymphoepithelioma-like carcinoma of the urinary bladder. , 2009, International journal of clinical and experimental pathology.

[145]  C. Dinney,et al.  The impact of variant histology on the outcome of bladder cancer treated with curative intent. , 2009, Urologic oncology.

[146]  A. Carmack,et al.  Nonurothelial cancer of the bladder. , 2007, Urology.

[147]  M. Zaghloul,et al.  Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients. , 2006, Urologic oncology.

[148]  S. Johansson,et al.  The nested variant of transitional cell carcinoma--a rare neoplasm with poor prognosis. , 2001, Scandinavian journal of urology and nephrology.

[149]  E. Jones,et al.  Myxoid and sclerosing sarcomatoid transitional cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 25 cases. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.